Corvus Pharmaceuticals (CRVS) Shares Outstanding (2022 - 2025)
Historic Shares Outstanding for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $74.7 million.
- Corvus Pharmaceuticals' Shares Outstanding rose 1933.82% to $74.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.7 million, marking a year-over-year increase of 1933.82%. This contributed to the annual value of $67.9 million for FY2024, which is 3846.2% up from last year.
- According to the latest figures from Q3 2025, Corvus Pharmaceuticals' Shares Outstanding is $74.7 million, which was up 1933.82% from $74.5 million recorded in Q2 2025.
- Corvus Pharmaceuticals' Shares Outstanding's 5-year high stood at $74.7 million during Q3 2025, with a 5-year trough of $46.6 million in Q1 2022.
- Over the past 4 years, Corvus Pharmaceuticals' median Shares Outstanding value was $49.0 million (recorded in 2023), while the average stood at $55.9 million.
- As far as peak fluctuations go, Corvus Pharmaceuticals' Shares Outstanding grew by 3.22% in 2023, and later soared by 3901.19% in 2025.
- Over the past 4 years, Corvus Pharmaceuticals' Shares Outstanding (Quarter) stood at $46.6 million in 2022, then rose by 5.34% to $49.0 million in 2023, then surged by 38.46% to $67.9 million in 2024, then rose by 9.99% to $74.7 million in 2025.
- Its last three reported values are $74.7 million in Q3 2025, $74.5 million for Q2 2025, and $68.2 million during Q1 2025.